Alison O’Mahony

2.1k citations

19 papers · 1.2k indexed · h-index 11

Co-authors: Warner C. Greene Romas Geleziunas Xin Lin Yajun Mu Stefan Knapp Susanne Müller O. Fedorov Christopher Wells
Topics: Monoclonal and Polyclonal Antibodies Research (5 papers)Protein Degradation and Inhibitors (3 papers)Cytokine Signaling Pathways and Interactions (3 papers)
Cited by: Hematology Immunology Genetics
Journals: Proceedings of the National Academy of Sciences The Journal of Immunology PLoS ONE
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Alison O’Mahony

18 papers receiving 1.2k citations

Peers

Countries citing papers authored by Alison O’Mahony

Since Specialization

Citations

This map shows the geographic impact of Alison O’Mahony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison O’Mahony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison O’Mahony more than expected).

Fields of papers citing papers by Alison O’Mahony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison O’Mahony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison O’Mahony. The network helps show where Alison O’Mahony may publish in the future.

Co-authorship network of co-authors of Alison O’Mahony

This figure shows the co-authorship network connecting the top 25 collaborators of Alison O’Mahony. A scholar is included among the top collaborators of Alison O’Mahony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison O’Mahony. Alison O’Mahony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	The First CRISPR-Based Therapeutic (SL_1.52) for African Swine Fever Is Effective in Swine 2025 ·Viruses ·(unknown),Alison O’Mahony,(unknown),(unknown),(unknown),(unknown),(unknown),Johann Bauer,(unknown),(unknown),(unknown),Angkana Tantituvanont,Dachrit Nilubol,Douglas P. Gladue	0
2	A tubulin binding molecule drives differentiation of acute myeloid leukemia cells 2022 ·iScience ·(unknown),(unknown),(unknown),(unknown),Daniel Conole,(unknown),(unknown),Laura M. Kettyle,(unknown),Alison O’Mahony,(unknown),(unknown),Robert Westwood,Georg C. Terstappen,Stephen G. Davies,Edward W. Tate,Graham M. Wynne,Paresh Vyas,Angela J. Russell,Thomas A. Milne	4
3	Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models 2019 ·The Journal of Immunology ·Philipp Haselmayer,Montserrat Camps,Lesley Liu‐Bujalski,Ngan Nguyen,Federica Morandi,Jared Head,Alison O’Mahony,Simone C. Zimmerli,Lisa Bruns,Andrew T. Bender,Patricia Schroeder,Roland Grenningloh	108
4	Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate 2018 ·Journal of Translational Medicine ·Alison O’Mahony,Markus R. John,Hanna Cho,Misato Hashizume,Ernest Choy	6
5	AB0050 Biomap® phenotypic profiling of two batches of originator etanercept reveals equivalent activity signatures consistent with conserved biological activity 2018 ·Annals of the Rheumatic Diseases ·Alison O’Mahony,Ellen L. Berg,Heather Jones,Brian Fitzpatrick,(unknown),(unknown),Lisa Marshall,(unknown),(unknown)	1
6	Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation 2018 ·Proceedings of the National Academy of Sciences ·Brian C. Betts,David Bastian,Supinya Iamsawat,Hung Nguyen,Jessica Heinrichs,Yongxia Wu,Anusara Daenthanasanmak,Anandharaman Veerapathran,Alison O’Mahony,Kelly Walton,(unknown),Pedro Horna,Elizabeth M. Sagatys,Marie Catherine Lee,Jack W. Singer,Ying‐Jun Chang,Chen Liu,Joseph Pidala,Claudio Anasetti,Xue‐Zhong Yu	53
7	Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators 2017 ·Cell chemical biology ·Falgun Shah,Antonia F. Stepan,Alison O’Mahony,Sharlene Velichko,Alexandra E. Folias,Christopher Houle,Christopher L. Shaffer,John Marcek,Jessica Whritenour,Robert V. Stanton,Ellen L. Berg	26
8	THU0180 Systems based investigation of the anti-immunogenic potential of dmards for rheumatoid arthritis using human primary cell-based biomap® phenotypic profiling 2017 ·Annals of the Rheumatic Diseases ·Alison O’Mahony,Ernest Choy	1
9	CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses 2015 ·Proceedings of the National Academy of Sciences ·Ariane Hammitzsch,C. Tallant,O. Fedorov,Alison O’Mahony,Paul E. Brennan,Duncan A. Hay,Fernando O. Martínez,Hussein Al‐Mossawi,Jelle de Wit,Matteo Vecellio,Christopher Wells,B P Wordsworth,Susanne Müller,Stefan Knapp,Paul Bowness	195
10	Elucidating Mechanisms of Toxicity Using Phenotypic Data from Primary Human Cell Systems—A Chemical Biology Approach for Thrombosis-Related Side Effects 2015 ·International Journal of Molecular Sciences ·Ellen L. Berg,Mark A. Polokoff,Alison O’Mahony,Dat Nguyen,(unknown)	20
11	Dual kinase-bromodomain inhibitors for rationally designed polypharmacology 2014 ·Nature Chemical Biology ·Pietro Ciceri,Susanne Müller,Alison O’Mahony,O. Fedorov,P. Filippakopoulos,Jeremy P. Hunt,Elisabeth A. Lasater,Gabriel Pallares,S. Picaud,Christopher Wells,Sarah Martin,Lisa Wodicka,Neil P. Shah,Daniel K. Treiber,Stefan Knapp	261
12	THU0526 Tocilizumab is Less Dependent than Adalimumab on Supplementary Effects of Methotrexate for Immunoregulation: A Biomap® Profiling Study 2014 ·Annals of the Rheumatic Diseases ·Alison O’Mahony,(unknown),Markus R. John,(unknown),(unknown)	4
13	Regulation of IL-17A Production Is Distinct from IL-17F in a Primary Human Cell Co-culture Model of T Cell-Mediated B Cell Activation 2013 ·PLoS ONE ·Andrew C. Melton,Jennifer Melrose,(unknown),(unknown),Hanna Cho,Naomi Brown,(unknown),Dat Nguyen,(unknown),Jian Yang,Mark A. Polokoff,Ivan Plavec,Ellen L. Berg,Alison O’Mahony	39
14	RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Daigen Xu,Yong Kim,Jennifer Postelnek,Minh Diem Vu,Dong‐Qing Hu,Cheng Liao,(unknown),Jonathan C. Hsu,Jun Zhang,Achal Pashine,(unknown),John Woods,(unknown),Alison O’Mahony,Timothy D. Owens,Yan Lou,Ronald J. Hill,Satwant K. Narula,Julie A. DeMartino,Jay S. Fine	105
15	NF-κB/Rel Regulates Inhibitory and Excitatory Neuronal Function and Synaptic Plasticity 2006 ·Molecular and Cellular Biology ·Alison O’Mahony,Jacob Raber,Mauricio Montaño,Erik D. Foehr,Victor Z. Han,(unknown),Hakju Kwon,Anthony LeFevour,(unknown),Warner C. Greene	92
16	Differentiation-dependent mechanisms of transcriptional regulation of the catalytic subunit of phosphorylase kinase 2002 ·Biochemical Journal ·Alison O’Mahony,Donal A. Walsh	1
17	Differentiation-dependent mechanisms of transcriptional regulation of the catalytic subunit of phosphorylase kinase 2002 ·Biochemical Journal ·Alison O’Mahony,Donal A. Walsh	1
18	Activation of the Heterodimeric IκB Kinase α (IKKα)-IKKβ Complex Is Directional: IKKα Regulates IKKβ under Both Basal and Stimulated Conditions 2000 ·Molecular and Cellular Biology ·Alison O’Mahony,Xin Lin,Romas Geleziunas,Warner C. Greene	103
19	Protein Kinase C-θ Participates in NF-κB Activation Induced by CD3-CD28 Costimulation through Selective Activation of IκB Kinase β 2000 ·Molecular and Cellular Biology ·Xin Lin,Alison O’Mahony,Yajun Mu,Romas Geleziunas,Warner C. Greene	228

About Alison O’Mahony

Alison O’Mahony is a scholar working on Immunology, Hematology and Genetics, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Protein Degradation and Inhibitors (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Hematology (256 citations), Immunology (462 citations) and Genetics (193 citations). Alison O’Mahony has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Warner C. Greene, Romas Geleziunas, Xin Lin, Yajun Mu, Stefan Knapp, Susanne Müller, O. Fedorov, Christopher Wells, P. Filippakopoulos and Lisa Wodicka. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact